Open Access

Looking PHorward to improving long-term outcomes in PAH

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Pulmonary Hypertension
Session type: Industry Q&A session
Sponsored by Janssen Pharmaceutica NV
Date: 29 August 2020
Time: 18:30 - 19:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Welcome and objectives

Speaker: Doctor L. Howard (London, GB)
Thumbnail

Making the correct diagnosis: Differentiating PAH from PH due to LHD

Speaker: Doctor M. Escribano Subias (Madrid, ES)
Thumbnail

The importance of imaging in assessing RV function in PAH

Speaker: Professor S. Rosenkranz (Cologne, DE)
Thumbnail

Achieving best long-term outcomes in PAH: How to choose the right treatments and when to start them

Speaker: Professor N. Galie (Bologna, IT)
Thumbnail

Panel discussion with audience Q&A

Thumbnail

Key messages and closing remarks

Speaker: Professor I. Lang (Vienna, AT)
Thumbnail

5 speakers from this session

Doctor Luke Howard

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Doctor Maria Pilar Escribano Subias

University Hospital 12 de Octubre, Madrid (Spain)
3 presentations
0 follower

Professor Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne (Germany)
20 presentations
0 follower

Professor Nazzareno Galie

Alma Mater Studiorum, University of Bologna, Bologna (Italy)
14 presentations
0 follower

Professor Irene Marthe Lang

Medical University of Vienna, Vienna (Austria)
28 presentations
0 follower

This platform is supported by

logo Novo Nordisk